Xytronyx Inc. extends standstill agreement regarding the Xytronyx Periodontal Tissue Monitor.SAN DIEGO--(BUSINESS WIRE)--Aug. 11, 1995--Xytronyx Inc. (ASE (Adaptive Server Enterprise) A relational DBMS from Sybase that runs on Windows NT/2000, Linux and a variety of Unix platforms. ASE is a comprehensive and robust data management product with a long history dating back to the late 1980s. :XYX) announced that it has agreed to extend for an additional five weeks the ``standstill agreement'' with a company based in the United States. As previously announced on July 7, 1995, Xytronyx will not enter into any agreements to market the Xytronyx Periodontal periodontal /peri·odon·tal/ (per?e-o-don´t'l) 1. pertaining to the periodontal ligament or periodontium. 2. near or around a tooth. per·i·o·don·tal adj. 1. Tissue Monitor during the period of the standstill agreement Standstill agreement Contract by which the bidding firm in a takeover attempt agrees to limit its holdings of another firm. standstill agreement . ``The extension gives Xytronyx and the company the time to finalize our respective evaluations of a possible marketing agreement between our two companies,'' said Larry Bymaster, chairman and chief executive officer of Xytronyx. ``We are continuing to evaluate other potential marketing partners based in both the United States and Europe.'' The Periodontal Tissue Monitor is designed to assist with the diagnosis and to monitor the effectiveness of treating periodontitis periodontitis Inflammation of soft tissues around the teeth (see tooth). Poor dental hygiene leads to deposition of bacterial plaque on the teeth below the gum line, irritating and eroding nearby tissues. , a common form of gum disease gum disease Dentistry Gingival disease, often in the form of gingivitis and bone loss 2º to toxins produced by bacteria in plaque accumulating along the gum line Clinical Early–painless bleeding; pain appears with advanced GD as bone loss around the and the leading cause of tooth loss in adults. The Periodontal Tissue Monitor has been approved for sale in certain Western European countries, Canada and the People's Republic of China. Clinical trials are currently being held in the United States, and Xytronyx expects after completion of the trials to file with the Food and Drug Administration for approval to market the product in the United States. CONTACT: Xytronyx Inc., San Diego Dale A. Sander or Larry Bymaster, 619/546-1114 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion